LATEST
Thu, Aug 27, 2026

Dhallo News

technology

FDA approves Priovant’s Lisraya for dermatomyositis treatment

FDA approves Priovant’s Lisraya for dermatomyositis treatment
Source: Investing.com News

More details on this developing story will follow.

Read More from technology

As onion touches ₹62 per kg, government blames middlemen for price rise

Farmers’ leader Rakesh Tikait had written to Prime Minister Narendra Modi and to...

Read Article »

Mosaic declares $0.22 dividend

Breaking News......

Read Article »

FreightCar America at Midwest IDEAS: gains share in railcar slump

Breaking News......

Read Article »
Return to Front Page